| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0009 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |